News & Dispatches
Press releases and essays from the CEO on the road to FDA authorization for patient-facing clinical AI.
Healthcare AI 2.0: The Dawn of Massively Scalable Clinical Capacity →
The FDA Shows More of Its Hand on Clinical GenAI →
RecovryAI Completes Patient Phase of Pivotal Trial Evaluating Its Clinical AI in Advance of FDA De Novo Filing →
The Regulatory Route to Prescribed AI: A Primer on Our FDA De Novo Pathway →
Two Economists Make the Argument for Virtual Care Assistants →
Outpatient Surgery's Not-So-Hidden Workload →
Inside the Regulatory Architecture of Prescribed AI →
The Emerging Third Lane of Healthcare AI →
RecovryAI Announces FDA Breakthrough Device Designation for Patient-Facing Clinical AI →
The Breakthrough Isn't the Story →